Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins

QR Code

Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins

Our knowledge regarding chemical structure and properties of heparin and its derivatives, including biological properties in blood plasma, on the cell surface and while interacting with receptors, has been progressively growing. New insights are followed by the expansion of therapeutic opportunities...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. O. Bitsadze, E. V. Slukhanchuk, J. Kh. Khizroeva, M. V. Tretyakova, N. V. Pyatigorskaya, S. V. Akinshina, N. A. Makatsariya, K. E. Gotsiridze, N. N. Babaeva, K. N. Grigoreva, A. S. Shkoda, I. Elalamy, J.-C. Gris, S. Shulman
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2021-07-01
Series:	Акушерство, гинекология и репродукция
Subjects:	heparin anticoagulants metastases inflammation covid-19
Online Access:	https://www.gynecology.su/jour/article/view/1010
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anticoagulants: dose control methods and inhibitors
by: V. O. Bitsadze, et al.
Published: (2022-05-01)

Heparin, Heparin-like Molecules, and Heparin Mimetics in Breast Cancer: A Concise Review
by: Diego R. Gatica Portillo, et al.
Published: (2025-07-01)

HEPARIN-INDUCED THROMBOCYTOPENIA IN PATIENT POST LIVER TRANSPLANTATION
by: M. Sh. Hubutija, et al.
Published: (2018-04-01)

Influence of low molecular weight heparin on cancer patients’ survival
by: V. V. Ptushkin
Published: (2014-07-01)

MODIFICATION AND METHOD OF DETERMINING OF ACTIVE GROUPS OF HEPARIN ON THE SURFACE OF SUTURE MATERIAL
by: T. N. Akentyeva, et al.
Published: (2019-01-01)

Potential targets of heparin during progression and metastasis of malignant neoplasms
by: V. V. Malashchenko, et al.
Published: (2024-01-01)

The methods of assessment of quality and safety of medicaments on the basis of low molecular weight heparins
by: E. A. Arianova, et al.
Published: (2011-09-01)

PLACE OF LOW-MOLECULAR-WEIGHT HEPARINS IN INTENSIVE THERAPY OF HEPATIC INSUFFICIENCY
by: A. N. Shmakov, et al.
Published: (2020-03-01)

Heparin (and related polysaccharides) : structural and functional properties /
by: Comper, Wayne D.
Published: (1981)

Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses
by: S. V. Akinshina, et al.
Published: (2021-11-01)

Immune paradoxes of vaccine-induced thrombotic thrombocytopenia (VITТ), heparin-induced thrombocytopenia (HIT) and thrombosis: from general mechanisms to the unique VITТ and HIT course
by: A. D. Makatsariya, et al.
Published: (2025-03-01)

Anticoagulant Potential of Modified Sulfated Exopolysaccharides from Deep-Sea Bacteria: Toward Non-Animal Heparin Alternatives
by: Antoine Babuty, et al.
Published: (2025-06-01)

PREGNANCY IN WOMEN WITH HISTORY OF ISCHEMIC STROKE AND THROMBOPHILIA
by: S. V. Akinshina, et al.
Published: (2016-06-01)

Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome
by: A. D. Makatsariya, et al.
Published: (2020-07-01)

Thrombocytopenia as a Side Effect of Heparin Therapy and COVID-19 Vaccination: A Review
by: S. S. Postnikov, et al.
Published: (2025-06-01)

Study of the Role of Heparin in Regulation of the Morphofunctional Properties of MSC <i>in Vitro</i>
by: I. K. Norkin, et al.
Published: (2022-05-01)

Management of antithrombin III deficiency in pregnancy: a representative case and a literature review
by: S. V. Akinshina, et al.
Published: (2021-09-01)

Pharmacokinetics of low molecular weight heparins in thrombosis, complicate the treatment of children with cancer
by: V. V. Dmitriev, et al.
Published: (2021-04-01)

VENOUS THROMBOEMBOLISM IN RELATION TO OVARIAN HYPERSTIMULATION SYNDROME: AN APPROACH TO DETERMINING THE LOW-MOLECULAR-WEIGHT-HEPARIN DOSES AND ACTIVITY
by: I. E. Zazerskaya, et al.
Published: (2016-06-01)

Off-pump coronary artery bypass with heparin in a patient with a history of heparin-induced thrombocytopenia: a case report
by: Yuya Ito, et al.
Published: (2021-12-01)

Endogenous heparin-like syndrome in obstetrics: a series of observations in obstetrics
by: O. S. Beznoshchenko, et al.
Published: (2025-04-01)

Low-molecular heparins in thrombolytic therapy of myocardial infarction patients
by: I. S. Yavelov
Published: (2009-12-01)

PLACENTAL INSUFFICIENCY IN COMPLICATED PREGNANCY AND POSSIBILITY OF TREATMENT WITH DIPYRIDAMOLE
by: A. D. Makatsariya, et al.
Published: (2017-03-01)

Thrombolysis versus unfractionated heparin for hemodynamically stable patients with pulmonary embolism: a systematic review and meta-analysis
by: N. A. Cherepanova, et al.
Published: (2022-09-01)

THROMBOPHILIA AND THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH USE OF ASSISTIVE REPRODUCTIVE TECHNOLOGIES
by: S. V. Akinshina, et al.
Published: (2016-06-01)

Efficacy and safety of long-term use of low molecular weight heparins in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2023-10-01)

Effect and mechanism of heparin on iodine contrast nephropathy: A bibliometric analysis
by: Wei Huang, et al.
Published: (2025-07-01)

Low-molecular-weight heparin-induced thrombocytopenia with multisite embolism: successful management with argatroban and dabigatran – a case report and literature review
by: Huixin Zhao, et al.
Published: (2025-07-01)

Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital
by: A. S. Kolbin, et al.
Published: (2015-03-01)

Heparin-Binding Hemagglutinin-Induced Trained Immunity in Macrophages: Implications for Antimycobacterial Defense
by: Yongqiang Li, et al.
Published: (2025-07-01)

Pregnancy in women with history of ischemic stroke and thrombophilia
by: A. D. Makatsariya, et al.
Published: (2016-06-01)

STIMULATING EFFECT OF HIGH DOSE HEPARIN ON MIGRATION ACTIVITY AND MSC STEMNESS PRESERVATION IN THE PRESENCE OF BONE-SUBSTITUTING MATERIALS
by: I. K. Norkin, et al.
Published: (2021-10-01)

Advisory Board conclusion following the discussion "Controversial issues of low molecular weight heparins use in obstetrics"
by: article Editorial
Published: (2021-09-01)

What has changed over the year in the prevention of venous thromboembolic events in pregnant women and puerperas?
by: V. O. Bitsadze, et al.
Published: (2023-09-01)

ECONOMIC EVALUATION OF THE EFFECTIVENESS OF LOW MOLECULAR WEIGHT HEPARIN AND INTERMITTENT PNEUMATIC COMPRESSION IN WOMEN IN A CYCLE OF IN VITRO FERTILIZATION
by: A. P. Momot, et al.
Published: (2015-03-01)

The role of platelets in antiviral immunity
by: E. V. Slukhanchuk, et al.
Published: (2022-05-01)

Innovative approaches to assessing risk factors, diagnostics and treatment of neonatal thrombosis
by: A. D. Makatsariya, et al.
Published: (2024-07-01)

Osteoporosis and antithrombotic therapy
by: N. V. Brailova, et al.
Published: (2021-06-01)

Heparin prophylaxis of gestational complications in women with Factor V Leiden mutation (GA genotype)
by: M. G. Nikolaeva, et al.
Published: (2018-08-01)

Corrigendum to «Innovative approaches to assessing risk factors, diagnostics and treatment of neonatal thrombosis» (https://doi.org/10.17749/2313-7347/ob.gyn.rep.2024.530)
by: A. D. Makatsariya, et al.
Published: (2024-11-01)